{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T03:59:13Z","timestamp":1760241553690,"version":"build-2065373602"},"reference-count":52,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2018,5,8]],"date-time":"2018-05-08T00:00:00Z","timestamp":1525737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Behavioral Sciences"],"abstract":"<jats:p>Neuroimmunology can be traced back to the XIX century through the descriptions of some of the disease\u2019s models (e.g., multiple sclerosis and Guillain Barret syndrome, amongst others). The diagnostic tools are based in the cerebrospinal fluid (CSF) analysis developed by Quincke or in the development of neuroimmunotherapy with the earlier expression in Pasteur\u2019s vaccine for rabies. Nevertheless, this field, which began to become delineated as an independent research area in the 1940s, has evolved as an innovative and integrative field at the shared edges of neurosciences, immunology, and related clinical and research areas, which are currently becoming a major concern for neuroscience and indeed for all of the scientific community linked to it. The workshop focused on several topics: (1) the molecular mechanisms of immunoregulation in health and neurological diseases, (like multiple sclerosis, autism, ataxias, epilepsy, Alzheimer and Parkinson\u2019s disease); (2) the use of animal models for neurodegenerative diseases (ataxia, fronto-temporal dementia\/amyotrophic lateral sclerosis, ataxia-telangiectasia); (3) the results of new interventional technologies in neurology, with a special interest in the implementation of surgical techniques and the management of drug-resistant temporal lobe epilepsy; (4) the use of non-invasive brain stimulation in neurodevelopmental disorders; as well as (5) the efficacy of neuroprotective molecules in neurodegenerative diseases. This paper summarizes the highlights of the symposium.<\/jats:p>","DOI":"10.3390\/bs8050047","type":"journal-article","created":{"date-parts":[[2018,5,8]],"date-time":"2018-05-08T02:48:08Z","timestamp":1525747688000},"page":"47","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Neuroimmunology Research. A Report from the Cuban Network of Neuroimmunology"],"prefix":"10.3390","volume":"8","author":[{"given":"Mar\u00eda de los Angeles","family":"Robinson-Agramonte","sequence":"first","affiliation":[{"name":"Neuroimmunology Laboratory, Immunochemical Department, International Center for Neurological Restoration, Ave 25 # 15805 b\/w 158 and 160, Playa, Havana 11300, Cuba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4913-0706","authenticated-orcid":false,"given":"Lourdes Lorigados","family":"Pedre","sequence":"additional","affiliation":[{"name":"Neuroimmunology Laboratory, Immunochemical Department, International Center for Neurological Restoration, Ave 25 # 15805 b\/w 158 and 160, Playa, Havana 11300, Cuba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2605-6999","authenticated-orcid":false,"given":"Orlando Ram\u00f3n","family":"Serrano-Barrera","sequence":"additional","affiliation":[{"name":"Las Tunas General Hospital, Post Office Box 27, Las Tunas 75100, Cuba"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2018,5,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.bbi.2006.07.003","article-title":"A global view of twenty years of brain, behavior, and immunity","volume":"21","author":"Ader","year":"2007","journal-title":"Brain Behav. Immun."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000150299","article-title":"T-cell autoimmunity in the central nervous system","volume":"35","author":"Wekerle","year":"1993","journal-title":"Intervirology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.bbi.2009.08.007","article-title":"The learned immune response: Pavlov and beyond","volume":"24","author":"Schedlowski","year":"2010","journal-title":"Brain Behav. Immun."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/clpt.2014.75","article-title":"Preserving learned immunosuppressive placebo response: Perspectives for clinical application","volume":"96","author":"Albring","year":"2014","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S1474-4422(15)00334-8","article-title":"The search for the target antigens of multiple sclerosis, part 1: Autoreactive CD4+ T lymphocytes as pathogenic effectors and therapeutic targets","volume":"15","author":"Hohlfeld","year":"2016","journal-title":"Lancet Neurol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1474-4422(15)00313-0","article-title":"The search for the target antigens of multiple sclerosis, part 2: CD8+ T cells, B cells, and antibodies in the focus of reverse-translational research","volume":"15","author":"Hohlfeld","year":"2016","journal-title":"Lancet Neurol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00115-014-4248-7","article-title":"Multiple sclerosis and microbiota. From genome to metagenome?","volume":"86","author":"Hohlfeld","year":"2015","journal-title":"Nervenarzt"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.it.2017.03.008","article-title":"Brain autoimmunity and intestinal microbiota: 100 trillion game changers","volume":"38","author":"Wekerle","year":"2017","journal-title":"Trends Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"ii68","DOI":"10.1093\/rheumatology\/kew353","article-title":"The gut-brain connection: Triggering of brain autoimmune disease by commensal gut bacteria","volume":"55","author":"Wekerle","year":"2016","journal-title":"Rheumatology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1002\/eji.201344133","article-title":"Immunity at the barriers","volume":"43","author":"Belkaid","year":"2013","journal-title":"Eur. J. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cell.2014.03.011","article-title":"Role of the microbiota in immunity and inflammation","volume":"157","author":"Belkaid","year":"2014","journal-title":"Cell"},{"key":"ref_12","first-page":"127","article-title":"The gut microbiota and its correlations with the central nervous system disorders","volume":"57","author":"Catanzaro","year":"2015","journal-title":"Panminerva Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"10713","DOI":"10.1073\/pnas.1711235114","article-title":"Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models","volume":"114","author":"Cekanaviciute","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"10719","DOI":"10.1073\/pnas.1711233114","article-title":"Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice","volume":"114","author":"Berer","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.4049\/jimmunol.1502322","article-title":"Maternal antibiotic treatment impacts development of the neonatal intestinal microbiome and antiviral immunity","volume":"196","author":"Hicks","year":"2016","journal-title":"J. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.medici.2015.03.001","article-title":"Symbiotic and antibiotic interactions between gut commensal microbiota and host immune system","volume":"51","author":"Malys","year":"2015","journal-title":"Medicina"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.it.2016.01.006","article-title":"Type I\/II interferon balance in the regulation of brain physiology and pathology","volume":"37","author":"Deczkowska","year":"2016","journal-title":"Trends Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41467-017-00769-0","article-title":"Mef2c restrains microglial inflammatory response and is lost in brain ageing in an IFN-I-dependent manner","volume":"8","author":"Deczkowska","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.it.2016.08.001","article-title":"Neurological disease as a failure of brain-immune crosstalk: The multiple faces of neuroinflammation","volume":"37","author":"Schwartz","year":"2016","journal-title":"Trends Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1073\/pnas.1211270110","article-title":"CNS-specific immunity at the choroid plexus shifts toward destructive TH2 inflammation in brain aging","volume":"110","author":"Baruch","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nm.4022","article-title":"PD-1 immune checkpoint blockade reduces pathology and improves memory in mouse models of alzheimer\u2019s disease","volume":"22","author":"Baruch","year":"2016","journal-title":"Nat. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1471-4159.2011.07612.x","article-title":"The S100B protein in biological fluids: More than a lifelong biomarker of brain distress","volume":"120","author":"Michetti","year":"2012","journal-title":"J. Neurochem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1007\/s12035-017-0526-2","article-title":"Systemic inflammation as a driver of brain injury: The astrocyte as an emerging player","volume":"55","author":"Bellaver","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s11302-015-9475-2","article-title":"Guanosine inhibits LPS-induced pro-inflammatory response and oxidative stress in hippocampal astrocytes through the heme oxygenase-1 pathway","volume":"11","author":"Bellaver","year":"2015","journal-title":"Purinergic Signal."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.pnpbp.2012.12.001","article-title":"Interleukin-6-induced S100B secretion is inhibited by haloperidol and risperidone","volume":"43","author":"Wartchow","year":"2013","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1742-2094-8-128","article-title":"Lipopolysaccharide modulates astrocytic S100B secretion: A study in cerebrospinal fluid and astrocyte cultures from rats","volume":"8","author":"Guerra","year":"2011","journal-title":"J. Neuroinflamm."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.brainresbull.2017.07.002","article-title":"Glial-associated changes in the cerebral cortex after collagenase-induced intracerebral hemorrhage in the rat striatum","volume":"134","author":"Neves","year":"2017","journal-title":"Brain Res. Bull."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"6766","DOI":"10.2174\/1381612811319380009","article-title":"Inflammatory mediators in epilepsy","volume":"19","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Lorigados Pedre, L., Morales Chacon, L.M., Pavon Fuentes, N., Robinson Agramonte, M.L.A., Serrano Sanchez, T., Cruz-Xenes, R.M., Diaz Hung, M.L., Estupinan Diaz, B., Baez Martin, M.M., and Orozco-Suarez, S. (2018). Follow-up of peripheral IL-1beta and IL-6 and relation with apoptotic death in drug-resistant temporal lobe epilepsy patients submitted to surgery. Behav. Sci., 8.","DOI":"10.3390\/bs8020021"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3389\/fncel.2013.00094","article-title":"Autism as early neurodevelopmental disorder: Evidence for an sappalpha-mediated anabolic pathway","volume":"7","author":"Lahiri","year":"2013","journal-title":"Front. Cell. Neurosci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1177\/1362361312472556","article-title":"Maladaptive cognitive appraisals in children with high-functioning autism: Associations with fear, anxiety and theory of mind","volume":"18","author":"Sharma","year":"2014","journal-title":"Autism Int. J. Res. Pract."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Inga Jacome, M.C., Morales Chacon, L.M., Vera Cuesta, H., Maragoto Rizo, C., Whilby Santiesteban, M., Ramos Hernandez, L., Noris Garcia, E., Gonzalez Fraguela, M.E., Fernandez Verdecia, C.I., and Vegas Hurtado, Y. (2016). Peripheral inflammatory markers contributing to comorbidities in autism. Behav. Sci., 6.","DOI":"10.3390\/bs6040029"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"20195","DOI":"10.1073\/pnas.1107560108","article-title":"Brain enlargement is associated with regression in preschool-age boys with autism spectrum disorders","volume":"108","author":"Nordahl","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_34","first-page":"275","article-title":"Targeted treatments for cognitive and neurodevelopmental disorders in tuberous sclerosis complex","volume":"7","year":"2010","journal-title":"Neurother. J. Am. Soc. Exp. NeuroTher."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.tins.2017.06.004","article-title":"Efficient prevention of neurodegenerative diseases by depletion of starvation response factor ataxin-2","volume":"40","author":"Auburger","year":"2017","journal-title":"Trends Neurosci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00412-014-0457-x","article-title":"Evolution of pas domains and pas-containing genes in eukaryotes","volume":"123","author":"Mei","year":"2014","journal-title":"Chromosoma"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e155","DOI":"10.1212\/NXG.0000000000000155","article-title":"Genetic analysis of age at onset variation in spinocerebellar ataxia type 2","volume":"3","author":"Figueroa","year":"2017","journal-title":"Neurol. Genet."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/mds.26555","article-title":"Central motor conduction time as prodromal biomarker in spinocerebellar ataxia type 2","volume":"31","author":"Montero","year":"2016","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/s12311-016-0827-4","article-title":"Corticomuscular coherence: A novel tool to assess the pyramidal tract dysfunction in spinocerebellar ataxia type 2","volume":"16","author":"Tunnerhoff","year":"2017","journal-title":"Cerebellum"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40673-017-0078-2","article-title":"Heritability of saccadic eye movements in spinocerebellar ataxia type 2: Insights into an endophenotype marker","volume":"4","year":"2017","journal-title":"Cerebellum Ataxias"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.bandc.2014.07.007","article-title":"Executive deficit in spinocerebellar ataxia type 2 is related to expanded cag repeats: Evidence from antisaccadic eye movements","volume":"91","year":"2014","journal-title":"Brain Cogn."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/mds.26532","article-title":"Spinocerebellar ataxia type 2: Measures of saccade changes improve power for clinical trials","volume":"31","author":"Auburger","year":"2016","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3389\/fneur.2017.00276","article-title":"Spinocerebellar ataxia type 2 is associated with the extracellular loss of superoxide dismutase but not catalase activity","volume":"8","year":"2017","journal-title":"Front. Neurol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jns.2016.11.075","article-title":"Association of glutathione S-transferase omega polymorphism and spinocerebellar ataxia type 2","volume":"372","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"11","DOI":"10.37757\/MR2012V14.N1.4","article-title":"Use of cuban recombinant human erythropoietin in parkinson\u2019s disease treatment","volume":"14","author":"Pedroso","year":"2012","journal-title":"MEDICC Rev."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Santos-Morales, O., Diaz-Machado, A., Jimenez-Rodriguez, D., Pomares-Iturralde, Y., Festary-Casanovas, T., Gonzalez-Delgado, C.A., Perez-Rodriguez, S., Alfonso-Munoz, E., Viada-Gonzalez, C., and Piedra-Sierra, P. (2017). Nasal administration of the neuroprotective candidate neuroepo to healthy volunteers: A randomized, parallel, open-label safety study. BMC Neurol., 17.","DOI":"10.1186\/s12883-017-0908-0"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.2174\/0929867321666140916120118","article-title":"The glutamate hypothesis in als: Pathophysiology and drug development","volume":"21","author":"Blasco","year":"2014","journal-title":"Curr. Med. Chem."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Hansel, G., Ramos, D.B., Delgado, C.A., Souza, D.G., Almeida, R.F., Portela, L.V., Quincozes-Santos, A., and Souza, D.O. (2014). The potential therapeutic effect of guanosine after cortical focal ischemia in rats. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0090693"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.tiv.2013.12.021","article-title":"Oxidative stress mediated by NMDA, AMPA\/KA channels in acute hippocampal slices: Neuroprotective effect of resveratrol","volume":"28","author":"Bobermin","year":"2014","journal-title":"Toxicol. In Vitro"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.neuint.2015.01.006","article-title":"The effects of JM-20 on the glutamatergic system in synaptic vesicles, synaptosomes and neural cells cultured from rat brain","volume":"81","author":"Ganzella","year":"2015","journal-title":"Neurochem. Int."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.neuint.2015.09.003","article-title":"Neuroprotection by JM-20 against oxygen-glucose deprivation in rat hippocampal slices: Involvement of the AKT\/GSK-3beta pathway","volume":"90","author":"Souza","year":"2015","journal-title":"Neurochem. Int."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Gomez, L., Vidal, B., Maragoto, C., Morales, L.M., Berrillo, S., Vera Cuesta, H., Baez, M., Denis, M., Marin, T., and Cabrera, Y. (2017). Non-invasive brain stimulation for children with autism spectrum disorders: A short-term outcome study. Behav. Sci., 7.","DOI":"10.3390\/bs7030063"}],"container-title":["Behavioral Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-328X\/8\/5\/47\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:03:40Z","timestamp":1760195020000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-328X\/8\/5\/47"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,8]]},"references-count":52,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,5]]}},"alternative-id":["bs8050047"],"URL":"https:\/\/doi.org\/10.3390\/bs8050047","relation":{},"ISSN":["2076-328X"],"issn-type":[{"type":"electronic","value":"2076-328X"}],"subject":[],"published":{"date-parts":[[2018,5,8]]}}}